These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 29445189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z, Qu L, Deng B, Sun X, Wu S, Liao J, Fan J, Peng Z.
    Sci Rep; 2016 Sep 15; 6():33205. PubMed ID: 27628214
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 8. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Yang B, Feng X, Liu H, Tong R, Wu J, Li C, Yu H, Chen Y, Cheng Q, Chen J, Cai X, Wu W, Lu Y, Hu J, Liang K, Lv Z, Wu J, Zheng S.
    Oncogene; 2020 Oct 12; 39(42):6529-6543. PubMed ID: 32917956
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R, Wu S, Lv X, Fang H, Wu S, Kang J.
    J Exp Clin Cancer Res; 2014 Dec 14; 33(1):105. PubMed ID: 25499255
    [Abstract] [Full Text] [Related]

  • 10. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 14; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 11. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H, Lan T, Xu L, Liu H, Wang J, Li J, Chen X, Huang J, Li X, Yuan K, Zeng Y, Wu H.
    J Exp Clin Cancer Res; 2020 Jul 06; 39(1):128. PubMed ID: 32631394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H, Xue L, Song C, Liu F, Jiang T, Yang X.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2659-2665. PubMed ID: 30086881
    [Abstract] [Full Text] [Related]

  • 17. Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail.
    Wu L, Feng H, Hu J, Tian X, Zhang C.
    Biomed Pharmacother; 2016 Dec 18; 84():1029-1035. PubMed ID: 27768928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
    Zhu MX, Wei CY, Zhang PF, Gao DM, Chen J, Zhao Y, Dong SS, Liu BB.
    J Exp Clin Cancer Res; 2019 Sep 18; 38(1):409. PubMed ID: 31533816
    [Abstract] [Full Text] [Related]

  • 20. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F, Zhang S, Song R, Liu Y, Wang J, Liang Y, Wang J, Han J, Song X, Lu Z, Yang G, Pan S, Li X, Liu Y, Zhou F, Wang Y, Cui Y, Zhang B, Ma K, Zhang C, Sun Y, Xin M, Liu L.
    EBioMedicine; 2019 Jun 18; 44():237-249. PubMed ID: 31176678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.